Kristina Striepe

Professur für Innere Medizin (Nephrologie)

Is GFR decline induced by SGLT2 inhibitor of clinical importance? (2024) Günes-Altan M, Bosch A, Striepe K, Bramlage P, Schiffer M, Schmieder R, Kannenkeril D Journal article Relation between waist circumference and the renal hemodynamic in healthy individuals (2024) Bosch A, Kannenkeril D, Ott C, Striepe K, Schiffer M, Schmieder R Journal article Current status of nephroprotection in diabetology Aktueller Stand der Nephroprotektion in der Diabetologie (2024) Schmieder R, Striepe K Journal article Renal adaptation in pre-obesity patients with hypertension (2024) Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder R, Kannenkeril D Journal article PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease (2024) Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Berner L, Pietschner R, Ott C, et al. Journal article Predicting blood pressure response to renal denervation based on a new approach (2024) Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Karg MV, Schmid A, Schiffer M, et al. Journal article Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis (2023) Staef M, Ott C, Kannenkeril D, Striepe K, Schiffer M, Schmieder R, Bosch A Journal article Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure (2023) Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, et al. Journal article Is vascular remodelling in patients with chronic heart failure exaggerated? (2022) Pietschner R, Bosch A, Kannenkeril D, Striepe K, Schiffer M, Achenbach S, Schmieder R, Kolwelter J Journal article PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease (2022) Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Pietschner R, Ott C, Schiffer M, et al. Conference contribution